2023 - Research.com Medicine in Belgium Leader Award
Prostate, Surgery, Urology, Pathology and Prostate cancer are his primary areas of study. His research in Prostate focuses on subjects like Hyperplasia, which are connected to Adenoma. His work deals with themes such as Internal medicine, Carcinoma and Transurethral microwave thermotherapy, which intersect with Surgery.
His Urology research integrates issues from Lower urinary tract symptoms, Randomized controlled trial, Antiandrogen and Urinary system. His study in Pathology is interdisciplinary in nature, drawing from both Cancer, Cancer research, Cadherin and Cellular differentiation. His Prostate cancer research includes themes of High-mobility group, Magnetic resonance imaging and In situ hybridization.
Frans M.J. Debruyne mainly focuses on Surgery, Urology, Prostate, Internal medicine and Pathology. His work on Surgery is being expanded to include thematically relevant topics such as Bladder outlet obstruction. In the field of Urology, his study on Urinary bladder overlaps with subjects such as In patient.
Frans M.J. Debruyne combines subjects such as Radiology, Prostate cancer and Hyperplasia with his study of Prostate. The various areas that Frans M.J. Debruyne examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology. His Pathology research is multidisciplinary, incorporating elements of Cancer, Cancer research and Antibody.
His primary areas of study are Surgery, Urology, Internal medicine, Prostate cancer and Prostate. He works on Surgery which deals in particular with Randomized controlled trial. His work carried out in the field of Urology brings together such families of science as Lower urinary tract symptoms, Quality of life, Urinary system, Randomization and Prostate-specific antigen.
His research in Internal medicine intersects with topics in Endocrinology and Oncology. His Prostate cancer study integrates concerns from other disciplines, such as Clinical trial and Zoledronic acid. Frans M.J. Debruyne is interested in International Prostate Symptom Score, which is a branch of Prostate.
His primary areas of investigation include Surgery, Urology, Internal medicine, Quality of life and Tibial nerve. His Surgery study incorporates themes from Prostatectomy and General surgery. His Urology research incorporates elements of Lower urinary tract symptoms, Prostate, Urinary system, Randomization and Watchful waiting.
His Prostate research is multidisciplinary, relying on both Biopsy, Magnetic resonance imaging, Prostate cancer and Hazard ratio. His work on Nephrology, Erectile dysfunction, Randomized controlled trial and Gonadotropin-releasing hormone antagonist as part of general Internal medicine study is frequently linked to Vardenafil, therefore connecting diverse disciplines of science. He has included themes like Urination and Anesthesia in his Tibial nerve study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
DD3::A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer
M.J.G. Bussemakers;A. van Bokhoven;G.W.C.T. Verhaegh;F.P. Smit.
Cancer Research (1999)
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.
Donald L. Lamm;Ad P.M. Van Der Meijden;Alvaro Morales;Stanley A. Brosman.
The Journal of Urology (1992)
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
Umbas R;Schalken Ja;Aalders Tw;Carter Bs.
Cancer Research (1992)
Decreased E-Cadherin Expression Is Associated with Poor Prognosis in Patients with Prostate Cancer
R. Umbas;W. B. Isaacs;P. P. Bringuier;H. E. Schaafsma.
Cancer Research (1994)
Decreased E-Cadherin Immunoreactivity Correlates with Poor Survival in Patients with Bladder Tumors
P. P. Bringuier;R. Umbas;H. E. Schaafsma;H. F. M. Karthaus.
Cancer Research (1993)
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
Marloes van der Leest;Erik Cornel;Bas Israël;Rianne Hendriks.
European Urology (2019)
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
Frans Debruyne;Gary Koch;Peter Boyle;Fernando Calais Da Silva.
European Urology (2002)
4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate Cancer
Claude C. Schulman;Frans M.J. Debruyne;Gerhard Forster;Francesco P. Selvaggi.
European Urology (2000)
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
Toru Shimazui;Jack A. Schalken;Laurence A. Giroldi;Cornelius F. J. Jansen.
Cancer Research (1996)
Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia
Frans Debruyne;Jack Barkin;Peter van Erps;Mario Reis.
European Urology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: